All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Placental growth factor may predict increased left ventricular mass index in patients with mild to moderate chronic kidney disease - a prospective observational study

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F13%3A10173666" target="_blank" >RIV/00216208:11110/13:10173666 - isvavai.cz</a>

  • Alternative codes found

    RIV/00064165:_____/13:10173666 RIV/00023884:_____/12:00007613

  • Result on the web

    <a href="http://dx.doi.org/10.1186/1471-2369-14-142" target="_blank" >http://dx.doi.org/10.1186/1471-2369-14-142</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1186/1471-2369-14-142" target="_blank" >10.1186/1471-2369-14-142</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Placental growth factor may predict increased left ventricular mass index in patients with mild to moderate chronic kidney disease - a prospective observational study

  • Original language description

    Background: Placental growth factor [PlGF) is a cardiovascular (CV) risk marker, which is related to left ventricle hypertrophy (LVH) in animal models. Currently there are no data available regarding the possible relationship of PlGF and the developmentof LVH or diastolic dysfunction in patients with chronic kidney disease (CKD) and the relationship of PlGF to other CV risk factors in CKD patients. The aim of our study was to determine the possible association of PlGF and several other CV risk markersto echocardiographic parameters in CKD population. Methods: We prospectively examined selected laboratory (PlGF, fibroblast growth factor-23 -FGF23, vitamin D, parathyroid hormone, extracellular newly identified RAGE-binding protein - EN-RAGE, B-type natriuretic peptide - BNP) and echocardiographic parameters in 62 patients with CKD 2-4. Mean follow-up was 36 +/- 10 months. Laboratory and echocardiographic data were collected 2-3 times, at the shortest interval of 12 months apart. Multiv

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FE - Other fields of internal medicine

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2013

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    BMC Nephrology

  • ISSN

    1471-2369

  • e-ISSN

  • Volume of the periodical

    14

  • Issue of the periodical within the volume

    JUL

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    9

  • Pages from-to

  • UT code for WoS article

    000322922500001

  • EID of the result in the Scopus database